| Theranostic advances in breast cancer in nuclear medicine N Vahidfar, A Aghanejad, H Ahmadzadehfar, S Farzanehfar, E Eppard International journal of molecular sciences 22 (9), 4597, 2021 | 61 | 2021 |
| Recent trends in diagnostic biomarkers of tumor microenvironment P Siminzar, MR Tohidkia, E Eppard, N Vahidfar, A Tarighatnia, ... Molecular Imaging and Biology 25 (3), 464-482, 2023 | 56 | 2023 |
| Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer PN Nabi, N Vahidfar, MR Tohidkia, AA Hamidi, Y Omidi, A Aghanejad International journal of biological macromolecules 174, 185-197, 2021 | 46 | 2021 |
| An impressive approach in nuclear medicine: theranostics N Vahidfar, E Eppard, S Farzanehfar, A Yordanova, M Fallahpoor, ... PET clinics 16 (3), 327-340, 2021 | 23 | 2021 |
| Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj Journal of Radioanalytical and Nuclear Chemistry 295, 979-986, 2013 | 22 | 2013 |
| Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts N Vahidfar, AR Jalilian, Y Fazaeli, A Aghanejad, A Bahrami-Samani, ... Radiochimica Acta 102 (7), 659-668, 2014 | 19 | 2014 |
| Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj Journal of Radioanalytical and Nuclear Chemistry 301, 269-276, 2014 | 19 | 2014 |
| Historical review of pharmacological development and dosimetry of PSMA-based theranostics for prostate cancer N Vahidfar, M Fallahpoor, S Farzanehfar, G Divband, H Ahmadzadehfar Journal of Radioanalytical and Nuclear Chemistry 322, 237-248, 2019 | 18 | 2019 |
| A review of nuclear medicine approaches in the diagnosis and the treatment of gynecological malignancies N Vahidfar, S Farzanefar, H Ahmadzadehfar, EN Molloy, E Eppard Cancers 14 (7), 1779, 2022 | 16 | 2022 |
| 177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis E Askari, S Harsini, N Vahidfar, G Divband, R Sadeghi Cancer biotherapy & radiopharmaceuticals 36 (5), 383-390, 2021 | 16 | 2021 |
| Preparation and biodistribution study of a 99mTc-labeled toxic fraction of Iranian mesobuthus eupeus scorpion venom SP Shirmardi, M Gandomkar, M Shamsaei, MA ZARE, MM GHANADI, ... IRANIAN JOURNAL OF NUCLEAR MEDICINE 18 (133), 37-44, 2010 | 14 | 2010 |
| Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-DOTA-TOC N Vahidfar, S Farzanehfar, M Abbasi, S Mirzaei, ES Delpassand, ... Cancers 14 (8), 1914, 2022 | 12 | 2022 |
| Preparation and validation of [67Ga]Ga-phytate kit and Monte Carlo dosimetry: an effort toward developing an impressive lymphoscintigraphy tracer Z Bayat, E Saeedzadeh, N Vahidfar, M Sadeghi, S Farzenefar, FJ Daha, ... Journal of Radioanalytical and Nuclear Chemistry 331 (2), 691-700, 2022 | 9 | 2022 |
| An overview of labeled porphyrin molecules in medical imaging N Vahidfar, AR Jalilian Recent Patents Topics Imaging 5, 3-12, 2015 | 5 | 2015 |
| Preparation of a 153Sm-5, 10, 15, 20-tetrakis (4-methoxyphenyl) porphyrin complex as a possible therapeutic agent N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj Iran J Nucl Med 23 (2), 65-72, 2015 | 4 | 2015 |
| Discordance between using estimated and measured glomerular filtration rate for drug dosing in kidney transplant recipients M Nabiee, N Vahidfar, S Dashti-Khavidaki, MR Khatami, M Abbasi, ... Iranian Journal of Kidney Diseases 15 (3), 213, 2021 | 3 | 2021 |
| Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine N Vahidfar, MB Kashi, S Afshar, P Sheikhzadeh, S Farzanefar, Y Salehi, ... Advances in Dosimetry and New Trends in Radiopharmaceuticals, 2024 | 2 | 2024 |
| Impact of attenuation correction, collimator, and iterative reconstruction protocols on 67Ga SPECT/CT quantification S Rezaei, S Farzanehfar, L Badrzadeh, F Assadi, N Vahidfar, ... Frontiers in Biomedical Technologies, 2023 | 2 | 2023 |
| Preparation and biological evaluation of a carrier free yttrium labelled porphyrin as a possible agent for targeted therapy of tumor M Abedi, MR Nabid, S Shirvani-Arani, A Bahrami-Samani, N Vahidfar Journal of Porphyrins and Phthalocyanines 21 (01), 24-30, 2017 | 2 | 2017 |
| Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine F Aghahosseini, Y Salehi, S Farzanefar, MB Kashi, E Eppard, ... Current radiopharmaceuticals, 2025 | 1 | 2025 |
Saeed FarzanehfarTehran Univesity of Medical SciencesVerified email at tums.ac.ir